| RS2507583743 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507584642 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507584919 |
STRC
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 16, Autosomal recessive nonsyndromic hearing loss 16 |
| RS2507585527 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507585886 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507586692 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507587176 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2507588285 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507588380 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507588444 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507588914 |
ZNF469
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2507589187 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507589689 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507589736 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507590369 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507590403 |
ZNF469
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS2507590620 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507591028 |
ZNF469
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS2507592045 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507592471 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507592636 |
GP1BA
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS2507593310 |
GP1BA
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Nonarteritic anterior ischemic optic neuropathy |
| RS2507593916 |
GP1BA
|
Health Risk |
Likely pathogenic |
Bernard-Soulier syndrome, type A1 |
| RS2507593936 |
STRC
|
Health Risk |
Likely pathogenic |
STRC-related disorder, STRC-related disorder |
| RS2507594138 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507594247 |
GP1BA
|
Health Risk |
Pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS2507594334 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507594973 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507595200 |
GP1BA
|
Health Risk |
Pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS2507595241 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507595775 |
STRC
|
Health Risk |
Likely pathogenic |
STRC-related disorder, STRC-related disorder |
| RS2507595797 |
STRC
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 16, Autosomal recessive nonsyndromic hearing loss 16 |
| RS2507595819 |
STRC
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 16, Autosomal recessive nonsyndromic hearing loss 16 |
| RS2507596154 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507596437 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507597158 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507597777 |
ZNF469
|
Health Risk |
Likely pathogenic |
— |
| RS2507597837 |
ZNF469
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS2507597886 |
STRC
|
Health Risk |
Likely pathogenic |
STRC-related disorder, STRC-related disorder |
| RS2507598029 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507598165 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507598343 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507599463 |
ZNF469
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2507599497 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507600316 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507601279 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507602020 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507602463 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507605413 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507606626 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2507609479 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2507610571 |
CTNS
|
Health Risk |
Pathogenic |
Ocular cystinosis, Ocular cystinosis |
| RS2507616467 |
SLC38A8
|
Health Risk |
Likely pathogenic |
Foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome, Foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome |
| RS2507618267 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507623414 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2507630439 |
WWOX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2507631270 |
SLC38A8
|
Health Risk |
Likely pathogenic |
— |
| RS2507631298 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507631710 |
SLC38A8
|
Health Risk |
Likely pathogenic |
— |
| RS2507632091 |
WWOX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2507633880 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2507641936 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 80, Retinitis pigmentosa 80 |
| RS2507642161 |
IFT140
|
Health Risk |
Likely pathogenic |
IFT140-related disorder, IFT140-related disorder |
| RS2507654719 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507655460 |
MAF
|
Health Risk |
Likely pathogenic |
MAF-related disorder, MAF-related disorder |
| RS2507659020 |
SLC38A8
|
Health Risk |
Likely pathogenic |
— |
| RS2507659253 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507659781 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507659879 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507659939 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507661713 |
GCSH
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 7, Multiple mitochondrial dysfunctions syndrome 7 |
| RS2507661763 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507661980 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507662681 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507662705 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507662751 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507663847 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507664082 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507664240 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507666683 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507666710 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507666723 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507666838 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507666862 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507666982 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507667622 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507668196 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507668346 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507668848 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507668893 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS2507668899 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507669361 |
GAN
|
Health Risk |
Pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS2507669416 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507672161 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507672211 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507672235 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507673070 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507673107 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS2507679454 |
GCSH
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 7, Multiple mitochondrial dysfunctions syndrome 7 |
| RS2507681732 |
SLC38A8
|
Health Risk |
Pathogenic |
— |